IM Cannabis (IMCC) Asset Writedowns and Impairment (2022 - 2024)
IM Cannabis' (IMCC) quarterly Asset Writedowns and Impairment came in at $347186.8 in Q4 2024, down 83.01% quarter-over-quarter from $2.0 million in Q1 2024.
IM Cannabis (IMCC) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends
IM Cannabis' Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $347186.8 for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 347,186.83 |
| Dec 31, 2024 | 347,186.83 |
| Mar 31, 2024 | 2.04 Mn |
| Mar 31, 2024 | 2.04 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Dec 31, 2022 | 3.04 Mn |